3′‐Hydroxypterostilbene Potently Suppresses Tumor Growth via Inhibiting the Activation of the JAK2/STAT3 Pathway in Ovarian Clear Cell Carcinoma
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202300108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Yen-Chun Koh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Food Sciences and Technology, National Taiwan University, Taipei, 10617, Taiwan. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Science and Technology Council, Taiwan.
Abstract (Originalsprache)
Scope Ovarian clear cell carcinoma (OCCC) is a subtype of epithelial ovarian cancer (EOC) that is associated with higher interleukin‐6 (IL‐6) levels, and suppression of the Janus kinase 2/Signal transducer and activator of transription 3 (JAK2/STAT3) pathway may contribute to the suppression of this cancer. This study aims to compare the anti‐cancer effect of pterostilbene (PSB) and 2’‐ and 3’‐hydroxypterostilbene (2HPSB and 3HPSB, respectively) on the JAK2/STAT3 pathway. Methods and results In vitro experiments with the OCCC cell line TOV21G and a xenograft nude mouse model are used to achieve the study aims. The results showed that 3HPSB has the greatest anti‐proliferative and pro‐apoptotic effects of the three compounds studied. Activation of the JAK2/STAT3 pathway and the nuclear translocation of STAT3 are effectively inhibited by 3HPSB and PSB. Both 3HPSB and PSB can effectively suppress tumor growth, which is mediated by the inhibition of JAK2/STAT3 phosphorylation. Conclusion This is the first study to compare the efficacy of PSB, 3HPSB, and the newly identified compound 2HPSB regarding ovarian cancer. Moreover, targeting JAK2/STAT3 is shown to be a potentially effective strategy for OCCC treatment. This study is expected to provide new insights into the potential of the abovementioned phytochemicals for development as adjuvants for cancer treatment in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Food Sciences and Technology, National Taiwan University, Taipei, 10617, Taiwan.
- Sabinsa Corporation, East Windsor, NJ, 08520, USA.
- Department of Food Science, Rutgers University, New Brunswick, NJ, 08901, USA.
- Department of Medical Research, China Medical University Hospital, China Medical University, Taichung City, 404, Taiwan.
- Department of Health and Nutrition Biotechnology, Asia University, Taichung City, 41354, Taiwan.
ORCID-Profile: Yen-Chun Koh, Kalyanam Nagabhushanam, Min-Hsiung Pan
Förderung
- National Science and Technology Council, Taiwan
Zitieren
APA
Koh, Y. C., Huang, W. Z., Nagabhushanam, K., Ho, C. T., & Pan, M. H. (2024). 3′‐Hydroxypterostilbene Potently Suppresses Tumor Growth via Inhibiting the Activation of the JAK2/STAT3 Pathway in Ovarian Clear Cell Carcinoma. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300108
Vancouver
Koh YC, Huang WZ, Nagabhushanam K, Ho CT, Pan MH. 3′‐Hydroxypterostilbene Potently Suppresses Tumor Growth via Inhibiting the Activation of the JAK2/STAT3 Pathway in Ovarian Clear Cell Carcinoma. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300108
BibTeX
@article{Koh2024,
author = {Koh, Yen-Chun and Huang, Wei-Zhe and Nagabhushanam, Kalyanam and Ho, Chi-Tang and Pan, Min-Hsiung},
title = {3′‐Hydroxypterostilbene Potently Suppresses Tumor Growth via Inhibiting the Activation of the JAK2/STAT3 Pathway in Ovarian Clear Cell Carcinoma},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202300108}
}
EUVIMED